2025

• Venditto, VJ*; Hudspeth, B; Freeman, PR; Qasrawi, L; Guy, RK; Farley, V; Johnson, R; Henson, D; Marion, R; Wagner, SB; Doratt, BM; Messaoudi, I. Feasibility of Pharmacy-based Research Opportunity to Enhance Community testing and Surveillance. JAPhA, 65, 102151, 2025.

2024

• Gusovsky, A; Slade, E; Forrest, JM; Henderson, D; Abdel-Latif, A; Venditto, VJ; Delcher, C; Feola, DJ. Azithromycin exposure in a 10-day window of myocardial infarction and short- & long-term cardiac and hospital utilization outcomes. JACC: Advances, 3, 101337, 2024.

2022

• Nardo, D; Pitts, M; Kaur, R; Venditto, VJ*. In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA. Biomater Sci, 10, 6968-6979, 2022. Invited Contribution
  
• Venditto, VJ*, Colón, K. Improving cultural humility by integrating health equity literature into the pharmacy curriculum. Pharmacy, 10(5), 116, 2022.
  
• Venditto, VJ; Sockolosky, J; Nguyen, J. Translational Drug Delivery: Time to be Frank for Future Success. Adv Drug Deliv Rev, 189, 114521, 2022.
  
• Masud, A; Alsharif, FM; Creameans, J; Perdeh, J; Feola, D; Venditto, VJ*. Optimization and characterization of liposomal azithromycin for alternative macrophage activation. Front Drug Del, Invited Contribution, In Press, 2022.
• Venditto, VJ*; Feola, D. Delivering macrolide antibiotics to heal a broken heart, and other inflammatory conditions. Adv Drug Del Rev, 184, 114252, 2022.

2021

• Nardo, D; Akers, CM; Cheung, NE; Isom CM; Spaude, JT; Pack DW; Venditto, VJ*. Cyanuric chloride as the basis for compositionally diverse lipids. RSC Adv, 11, 24752-24761, 2021
• Venditto, VJ; Haydar, D; Abdel-Latif, A; Gensel, JC; Anstead, MI; Pitts, M; Creameans, J; Kopper, T; Peng, C; Feola, DJ. Immunomodulatory effects of azithromycin revisited: Potential applications to COVID-19. Front Immunol, 12, Article 574425, 2021.

2020

• Al-Darraji, A; Donahue, R; Tripathi, H; Peng, H; Levitan, B; Chelvarajan, L; Haydar, D; Gao, E; Henson, D; Gensel, JC; Feola DJ; Venditto, VJ; Abdel-Latif, A. Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction. Sci Reports, 10, 16596, 2020.
• Venditto, VJ*; Hudspeth, B; Freeman, PR; Kebodeaux, C; Guy, KR. University-pharmacy partners for COVID-19. Science, 369, 1441, 2020.
• Creameans, J; Pitts, M; White, O; Greenwell, K; Colón, K; Garneau-Tsodikova, S; Venditto, VJ*. Have you heard? Everything is Science. Front Commun, 6, Article 68, 2020.
• Pitts, M; Nardo, D; Isom, C; Venditto, VJ*. Western type diet induces sexually dimorphic antibody responses in C57BL/6 mice. ImmunoHorizons, 4, 455-463, 2020.
• Nardo, D; Henson, D; Springer, J; Venditto, VJ*. Chapter 6: Modulating the immune response with liposomal drug delivery. In Demetzos C & Pippa N (Eds.) Nanomaterials in Clinical Medicine: Case Studies in Nanomedicines. Amsterdam, The Netherlands, Elsevier, 159-211, 2020.

2019

• Henson, D; Tahhan, AS; Nardo, D; Quyyumi, AA; Venditto, VJ*. Association between apolipoprotein A-I immune complexes and adverse cardiovascular events. Arterio Thromb Vasc Biol, 39, 1884-1892, 2019. (author retracted)

2018

• Al-Darraji, A; Haydar, D; Chelvarajan, L; Tripathi, H; Levitan, B; Gao E; Venditto, VJ; Gensel, J; Feola, DJ; Abdel-Latif, A. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. PLoS One, 13, e0200474, 2018.

2015

• Michelsen, CF; Jensen, H; Venditto, VJ; Hennessy, RC; Stougaard, P. Bioactivities by a crude extract from Greenlandic Pseudomonas sp. In5 involves the nonribosomal peptides, nunamycin and nunapeptin. PeerJ, 3, e1476, 2015.
• Kierstead, P; Okochi, H; Venditto, VJ; Chuong, TC; Kivimae, S.; Szoka, FC. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J Control Rel 213, 1-9, 2015.

2014

• Julien, O; Kampmann, M; Bassik, M; Zorn, J; Venditto, VJ; Shimbo, K; Agard, N; Rheingold, AL; Stockwell, B; Weissman, JS; Wells, JA. Unraveling the mechanism of cell death induced by chemical fibrils. Nature Chem Biol, 10(11) 969-976, 2014. PMC4201873
• Venditto, VJ; Dolor, A; Kohli, A.; Szoka, FC. Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids. Chem Commun 50(65) 9109-9111, 2014. PMC4214375.
• Venditto, VJ; Wieczorek, L; Molnar, S; Teque, F; Landucci, G; Watson, DS; Forthal, D; Polonis, V; Levy, JA; Szoka, FC, Jr. Chemically modified peptides based on the membrane proximal external region of HIV-1 envelope induce high titer, epitope specific nonneutralizing antibodies in rabbits. Clin Vaccine Immunol, 21(8) 1086-1093, 2014. PMC4135905
• Kohli, A; Kierstead, P; Venditto, VJ; Walsh, C; Szoka, FC. Designer lipids for drug delivery: From heads to tails. J Contr Rel 190C, 274-287, 2014. PMC4142081

2013

• Shetlar, MD; Hom, K; Venditto, VJ. Photohydrate-mediated reactions of uridine, 2’-deoxyuridine and 2’-deoxycytidine with amines at near neutral pH. Photochem Photobiol 89(4) 869-877, 2013. PMC3701732
• Venditto, VJ; Watson, DS; Motion, M; Montefiori, D; Szoka, FC, Jr. Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination. Clin. Vaccine Immunol. 20(1) 39-45, 2013. PMCID: PMC3535774.
• Venditto, VJ; Szoka, FC, Jr. Cancer nanomedicines: So many papers and so few drugs! Adv. Drug Deliv. Rev. 65, 80-88, 2013. PMCID: PMC3565003.
• Jameson, DL; Field, T; Schmidt, MR; DeStefano, AK; Stiteler, CJ; Venditto, VJ; Krovic, B; Hoffman, CM; Ondisco, M; Belowich, M. Application of crystallization-induced asymmetric transformation to a general, scalable method for the resolution of 2,8-disubstituted Troger’s base derivatives. J Org Chem 78(22) 11590-11596, 2013.

2011

• Watson, DS; Platt, VM; Cao, L; Venditto, VJ; Szoka, FC. Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice. Clin. Vaccine Immunol. 18 (2), 289-297, 2011. PMCID: PMC3067350.

2010

•  Lim, JD; Venditto, VJ; Simanek, EE. Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using twelve desferrioxamine B groups. Bioorg Med Chem 18 (15), 5749-5753, 2010. PMC3619556

2009

• Venditto, VJ; Simanek EE. Cancer therapies utilizing the camptothecins: a review of in vivo literature. Molec Pharmaceut 7 (2): 307-349, 2009. PMC3733266
• Venditto, VJ; Allred, K; Allred, C; Simanek, EE. Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles. Chem Commun 5541-5542, 2009. PMC3881288.
• Simanek, EE; Abdou, H; Lalwani, S; Lim, J; Mintzer, M; Venditto, VJ, Vittur, B. The eight-year thicket of triazine dendrimers: strategies, targets and applications. Proc Royal Soc, A 466 (2117), 1445-1468, 2009.
• Lalwani, S; Venditto, VJ; Chouai, A; Rivera, GE; Shaunak, S; Simanek, EE. Electrophoretic behavior of anionic triazine and PAMAM dendrimers: Methods for improving resolution and assessing purity using capillary electrophoresis. Macromolecules 42 (8): 3152-3161, 2009. PMCID: PMC2923459.
• Chouai, A; Venditto, VJ; Simanek, EE. Large scale, green synthesis of a generation-1 melamine (triazine) dendrimer. Org Syn 86: 151-160, 2009. PMCID: PMC2805095.
• Chouai, A; Venditto, VJ; Simanek, EE. Synthesis of 2-[3,3’-di-(tertbutoxycarbonyl)-aminodipropylamine]-4,6-dichloro-1,3,5-triazine as a monomer and 1,3,5-[tris-piperazine]-triazine as a core for the large scale synthesis of melamine (triazine) dendrimers. Org Syn 86: 141-150, 2009. PMCID: PMC2750910.

2005

• Torti, SV; Ma, R; Venditto, VJ; Torti, FM; Planalp, RP; Brechbiel, MW. Preliminary evaluation of the cytotoxicity of a series of tris-2-aminoethylamine (tren) based hexadentate heterocyclic donor agents. Bioorg Med Chem 13: 5961-5967, 2005.
• Venditto, VJ; Regino, CAS; Brechbiel, MW. PAMAM dendrimer based macromolecules as improved contrast agents. Molec Pharm 2: 302-311, 2005.

2004

• Camphausen, K; Sproull, M; Tantama, S; Venditto, V; Sankinemi, S; Scott, T; Brechbiel, MW. Evaluation of chelating agents as anti-angiogenic therapy through copper chelation. Bioorg Med Chem 12: 5133-5140, 2004.

2003

• Chappell, LL; Ma, D; Milenic, DE; Garmestani, K; Venditto, V; Beitzel, MP; Brechbiel, MW. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid for radiolabeling proteins. Nucl Med Biol 30: 581-595, 2003.

• 1.    Gusovsky, A; Slade, E; Forrest, JM; Henderson, D; Abdel-Latif, A; Venditto, VJ; Delcher, C; Feola, DJ. Azithromycin exposure in a 10-day window of myocardial infarction and short- & long-term cardiac and hospital utilization outcomes. JACC: Advances, 3, 101337, 2024.1.    Venditto, VJ*; Hudspeth, B; Freeman, PR; Qasrawi, L; Guy, RK; Farley, V; Johnson, R; Henson, D; Marion, R; Wagner, SB; Doratt, BM; Messaoudi, I. Feasibility of Pharmacy-based Research Opportunity to Enhance Community testing and Surveillance. JAPhA, 65, 102151, 2025.